Enzyme replacement therapy shows promise in Niemann-Pick disease type B
Will focus on development of next-generation tumor necrosis factor (TNF) blockers to generate drug candidates for IBD
Doubles capacity for biologics contract testing and biosimilar characterization
Features parts inventory for Cadmach, Colton, Fette, Kikusui, Kilian, Korsch, Manesty, Natoli and Stokes machines
Sign up now to receive the free weekly newsletter, and more!